Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Eclinicalmedicine
|
August 8, 2024
Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial
Sarah M Nicholson, Karen Flood, Patrick Dicker, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 16, 2016
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers
Philip J O'Halloran, Thomas Viel, David W Murray, et al.
Cancers
|
December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies
Kate Connor, David W Murray, Monika A Jarzabek, et al.
BMJ Open
|
July 30, 2018
<i>T</i>rial of feasibility and acceptability of routine low-dose aspirin versus <i>E</i>arly <i>S</i>creening <i>T</i>est indicated aspirin for pre-eclampsia prevention (<i>TEST</i> study): a multicentre randomised controlled trial
Fionnuala Mone, Cecilia Mulcahy, Peter McParland, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 22, 2020
Inter-hospital comparison of Cesarean delivery rates should not be considered to reflect quality of care without consideration of patient heterogeneity: An observational study
Niamh C Murphy, Naomi Burke, Fionnuala M Breathnach, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
December 8, 2024
Logistics for achieving delivery: A secondary analysis of the home induction randomised controlled trial
Sarah M Nicholson, Karen Flood, Patrick Dicker, et al.
Cancers
|
October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
Alice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer
Adam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
Therapeutic Advances in Medical Oncology
|
August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial
Giuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
BMJ Open
|
March 12, 2024
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George A Antoniou, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Eclinicalmedicine
|
August 8, 2024
Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial
Sarah M Nicholson, Karen Flood, Patrick Dicker, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 16, 2016
Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers
Philip J O'Halloran, Thomas Viel, David W Murray, et al.
Cancers
|
December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies
Kate Connor, David W Murray, Monika A Jarzabek, et al.
BMJ Open
|
July 30, 2018
<i>T</i>rial of feasibility and acceptability of routine low-dose aspirin versus <i>E</i>arly <i>S</i>creening <i>T</i>est indicated aspirin for pre-eclampsia prevention (<i>TEST</i> study): a multicentre randomised controlled trial
Fionnuala Mone, Cecilia Mulcahy, Peter McParland, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 22, 2020
Inter-hospital comparison of Cesarean delivery rates should not be considered to reflect quality of care without consideration of patient heterogeneity: An observational study
Niamh C Murphy, Naomi Burke, Fionnuala M Breathnach, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
December 8, 2024
Logistics for achieving delivery: A secondary analysis of the home induction randomised controlled trial
Sarah M Nicholson, Karen Flood, Patrick Dicker, et al.
Cancers
|
October 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models
Alice C O'Farrell, Monika A Jarzabek, Andreas U Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer
Adam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
Therapeutic Advances in Medical Oncology
|
August 7, 2019
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial
Giuseppe Gullo, Alex J Eustace, Alexandra Canonici, et al.
BMJ Open
|
March 12, 2024
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson, Calvin Heal, George A Antoniou, et al.
Page
of 13